T
CLOV icon

Tidemark’s Clover Health Investments CLOV Stock Holding History

Tidemark’s Portfolio CLOV Stock Details CLOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,000
Closed -$794 – 642
2024
Q1 		$794 Hold
1,000
– – ﹤0.01% 650
2023
Q4 		$952 Buy
+1,000
New +$982 ﹤0.01% 644

Other funds holding CLOV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Tidemark's CLOV Position: Q2 2024 in Review

Tidemark sold out of Clover Health Investments (CLOV) in Q2 2024, closing a stake of 1,000 shares — an estimated $794 sold.

Tidemark first reported a position in CLOV in Q4 2023 and held it in 2 quarters. The position peaked at $952 in Q4 2023. 127 funds tracked by Wall St. Rank hold CLOV as of Q2 2024.

  • Tidemark reported no remaining Clover Health Investments position as of Q2 2024 after selling out during the quarter.
  • Tidemark sold 1,000 Clover Health Investments shares in Q2 2024, an estimated $794.
  • Tidemark first reported a position in Clover Health Investments in Q4 2023 and held it in 2 quarters.
  • Tidemark's Clover Health Investments position peaked at $952 in Q4 2023.
  • 127 funds tracked by Wall St. Rank held Clover Health Investments as of Q2 2024.

Based on Tidemark's 13F filing for Q2 2024, filed 12 Aug 2024.